Course and treatment of buprenorphine/naloxone withdrawal: An analysis of case reports

American Journal on Addictions

Volumn 21, Issue 5, 2012, Pages 401-403

  Westermeyer, Joseph ^a,b   McCance Katz, Elinore F ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; DIAMORPHINE; METHADONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; COLD; DRUG DOSE ESCALATION; FEMALE; HEROIN DEPENDENCE; HUMAN; LACRIMATION; MAINTENANCE THERAPY; MALE; MYALGIA; OPIATE ADDICTION; PATIENT COMPLIANCE; RHINORRHEA; TREATMENT DURATION; TREATMENT WITHDRAWAL; WITHDRAWAL SYNDROME;

ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84865042597     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2012.00259.x     Document Type: Article

References (5)

1. Ling W, Hillhouse M, Domier C, et al,. Buprenorphine tapering schedule and illicit opioid use. Addiction. 2009; 104: 256-265.
2. Weiss RD, Potter JS, Fiellin DA, et al,. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011; 68: 1238-1246.
3. Urban V, Sullivan R,. Buprenorphine rescue from naltrexone-inducted opioid withdrawal during relatively rapid detoxification from high-dose methadone. Psychiatry. 2008; 5: 56-58.
4. Fudala PJ, Bridge TP, Herbert S, et al,. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003; 349: 949-958. (Pubitemid 37064768)
5. Ball JC, Corty E,: Basic issues pertaining to the effectiveness of methadone maintenance treatment. NIDA Res Monogr. 1988; 86: 178-191.